We are honoured to share this week’s BioLinks filled with exciting updates and news. First, please join us in welcoming James Bacon, LSBC’s new Manager, Memberships and Partnerships. James joins us with 12 years of experience in fundraising and corporate partnerships in the UK and Canada. If you see James at an upcoming LSBC event, be sure to say ‘hi’!
This week, I was thrilled to attend MaRS Impact Health 2022 and participate in a panel discussion on how the Canadian life sciences sector can get better at commercializing our discoveries and anchoring them here. On June 1st, I am excited to be on a panel at the VANTEC investor event to highlight the trends and future of the health and life sciences sector. The future of our sector is incredibly promising, and events like these underscore the importance of investing in and supporting the sector’s continued growth.
One of the hallmarks of our thriving life sciences sector is the supportive nature of our community, and we are proud to champion the important work taking place alongside our colleagues. This month we joined several LSBC members in Sweatin’ for Science, Science Fair Foundation BC’s 2nd annual Fitness FUNdraiser to help raise awareness and funds for all youth in BC + Yukon to pursue their interests in STEM fields. Another organization that plays a key role in fostering a love of STEM disciplines in young people is Science World. As they embark on a new visioning process, we invite you to participate in this online survey to help shape the future of science for the next generation!
We have some exciting events on the horizon, such as our BC Showcase: BIO San Diego on June 8th. This event comes ahead of BIO International Convention in San Diego from June 13-16th, where the BC delegation will be represented by 25+ companies in our province. This year’s theme is “Limitless Together”, and will highlight the health care innovations, business development and the exciting future of biotechnology. We look forward to seeing many of you there!
In the spirit of networking, we also invite you to join us for our LSBC Summer Social on June 23rd, a unique opportunity to connect with peers and stakeholders while enjoying kicking off the summer season! Spaces are limited, so register today! Finally, there is less than a week left to nominate someone for our annual LSBC Awards presented by FARRIS, which will be held on September 22nd. Nominations for these awards are due on June 1st, so make sure you nominate a deserving candidate!
Until next week,
Wendy and the LSBC team
|
|
|
|
LSBC's Annual Awards presented by Farris are now open for nominations.
These awards highlight groundbreaking achievements in BC's thriving sector.
Deadline: June 1, 2022.
|
|
|
|
Horizon Therapeutics plc to Present MIRROR Randomized Controlled Trial Primary Endpoint Data at The EULAR 2022 European Congress of Rheumatology
Horizon Therapeutics plc announced a series of data presentations during The EULAR 2022 European Congress of Rheumatology, June 1–4 in Copenhagen. As part of Horizon’s efforts to continually improve the understanding and treatment of gout, the company will present data on KRYSTEXXA® (pegloticase injection), including 6 month results from the MIRROR randomized controlled trial, and data from the PROTECT trial... READ MORE
|
|
|
|
Merck KGaA, Darmstadt, Germany, Invests More Than €440 Million and Expands its Membrane and Filtration Manufacturing in Ireland
Merck KGaA, Darmstadt, Germany is expanding its membrane and filtration manufacturing capabilities in Ireland. The company will invest approximately €440 million to increase membrane manufacturing capacity in Carrigtwohill and to build a new manufacturing facility at Blarney Business Park, both in Cork, Ireland... READ MORE
|
|
|
|
Pfizer Presents ELEVATE Pivotal Findings Demonstrating Etrasimod’s Potentially Best-in-Class Profile in Ulcerative Colitis
Pfizer Inc. announced detailed results from two pivotal studies that make up the ELEVATE UC Phase 3 registrational program evaluating etrasimod, a once-daily, oral, selective sphingosine 1-phosphate receptor modulator for the treatment of moderately-to-severely active ulcerative colitis... READ MORE
|
|
|
|
Roche Develops Unique PCR Tests to Detect the Monkeypox Virus
Roche and its subsidiary TIB Molbiol have developed three unique LightMix® Modular Virus kits in response to recent monkeypox virus concerns. Multiple clusters of the monkeypox virus have been reported within the past two weeks in several European countries and North America, which are regions where the virus is not normally found... READ MORE
|
|
|
|
Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose
Pfizer Inc. and BioNTech SE announced topline safety, immunogenicity and vaccine efficacy data from a Phase 2/3 trial evaluating a third 3-µg dose of the Pfizer-BioNTech COVID-19 Vaccine in children 6 months to under 5 years of age. Following a third dose in this age group, the vaccine was found to elicit a strong immune response, with a favorable safety profile similar to placebo... READ MORE
|
|
|
|
Data at the 2022 ASCO Annual Meeting Highlight Roche’s Continued Commitment to Innovation in Oncology and Personalised Healthcare
Roche announced that new data from clinical trials of 18 approved and investigational medicines across more than 20 cancer types will be presented at the 2022 American Society of Clinical Oncology Annual Meeting, which will be held June 3-7, 2022. Roche and its partners will present clinical studies across medicines, comprehensive genomic tests, and real-world data at this year’s meeting... READ MORE
|
|
|
|
EY Recognizes 24 Pacific Businesses in Annual Entrepreneur Program
EY Canada is honoured to announce the regional finalists in the EY Entrepreneur Of the Year® 2022 Pacific program. Selected by an independent panel of judges, 24 businesses have been recognized for transforming our world through unbounded innovation, growth and prosperity... READ MORE
|
|
|
|
BC Children’s Hospital Announces First of Its Kind Stem Cell Research Technology
BC Children’s Hospital Foundation announced the launch of new stem cell research technology at BC Children’s Hospital, which for the first time in history will combine and automate all aspects of stem cell culturing into a single piece of equipment. This technology could hold the key to more rapidly discovering new treatments or cures for severe childhood illnesses. Housed within the hospital’s Cellular and Regenerative Medicine Centre... READ MORE
|
|
|
|
Applied Cells Enters into a Supply Agreement with STEMCELL Technologies on Reagent Kits for Use in a Next-Generation Solution for Cell Separation
Applied Cells Inc. and STEMCELL Technologies Canada Inc. have announced their collaboration to deliver a new high-performance cell separation solution that combines Applied Cells’ MARS® platform with STEMCELL’s EasySep™ immunomagnetic cell separation kits. This partnership will help researchers around the world to automate and increase the efficiency of isolating high-quality cells from a wide range of sample types such as whole blood, bone marrow, apheresis products, and dissociated tissue... READ MORE
|
|
|
|
BC Tech Leaders Raise Funds and Awareness for STEM Education
BC’s tech leaders are Sweatin’ for Science this month to raise funds and awareness for science education. AbCellera, Genome BC, Aspect Biosystems, Xenon, Alyssa B Events, Blackbird Interactive, Marr Media, Science Fair Foundation BC, Evonik Lipo-Zooms, StandardFusion, Life Sciences BC, Jam PR and NR Pinnacle are among the teams who are logging their kilometres and collecting donations. ..READ MORE
|
|
Research Associate, Analytical Chemistry
We are seeking an analytical chemistry-focused Research Associate to join our CMC team. Reporting to the Senior Scientist, CMC Analytical, the Research Associate will work flexibly across a number of small molecule drug development programs with an emphasis on developing analytical methods that will then be transferred, as appropriate, to external cGMP testing labs.
|
|
Laboratory Animal Technician
Let’s do this. Let’s change the world! In this vital role you will support animal-based studies, husbandry, and vivarium operations and also act as a back-up for technical and lab support for in-vivo research. We are all different, yet we all use our unique contributions to serve patients. The detail oriented professional we seek is a great teammate with these qualifications
|
|
Data Analyst
We are seeking a Data Analyst with a deep understanding of the drug development process. The ideal candidate will work cross-functionally within the company to analyze relevant market and business data in drug discovery and commercialization. Join us on our mission to bring new treatment options to patients by revolutionizing drug discovery!
|
|
Boreal Genomics is a dynamic biotech company that has developed a revolutionary new approach for NGS target enrichment. This innovation enables rapid and efficient analysis of DNA for applications including oncology, gene editing and single cell genomics. Boreal is expanding its team in conjunction with a major partnership that will enable them to bring this technology to market for the benefit of cancer patients worldwide.
|
|
RUCBC works with and on behalf of its members to improve the quality, accessibility and coordination of university education in British Columbia. The Council provides a single voice on behalf of the six research universities on public policy issues including funding, research, accountability, admissions and transfer.
|
|
|
|
Post A Job on the LSBC Website! |
LSBC Membership Discounts on Job Postings
As an LSBC member, your first five job postings EARNS a free repost on BioTalent Canada's The Petri Dish. After your first five reposts, you will also receive 25% off all job postings on The Petri Dish. Want more info? Contact Megan Pan -talent@lifesciencesbc.ca
|
|
|
|
|
|
|
